Submit Deal

MERUS B.V.

HQ - Utrecht

Summary

Merus N.V. is a clinical-stage immuno-oncology company focused on developing innovative full-length bispecific antibody therapeutics.

Deals Overview

Total Deals3

Valued Deals2

Total Value£ 5.91 B

Avg. Deal Size£ 2.96 B

Market Context

Senior Management

Sort

Target: MERUS B.V.

Bidder: INCYTE CORPORATION

1 Service Providers

1 Dealmakers

n/a

Value

Target: MERUS B.V.

Bidder: ELI LILLY AND COMPANY

3 Service Providers

4 Dealmakers

£ 14 M

Value

Target: MERUS B.V.

Bidder: GENMAB AS

10 Service Providers

55 Dealmakers

£ 5.90 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy